National trends and disparities in herpes zoster vaccination among US older adults with chronic obstructive pulmonary disease, 2008 to 2022.

IF 3.8 3区医学 Q2 INFECTIOUS DISEASES

American journal of infection control Pub Date : 2024-08-15 DOI:10.1016/j.ajic.2024.08.010

Chun-Tse Hung, Li-Min Wang, Chi-Won Suk

{"title":"National trends and disparities in herpes zoster vaccination among US older adults with chronic obstructive pulmonary disease, 2008 to 2022.","authors":"Chun-Tse Hung, Li-Min Wang, Chi-Won Suk","doi":"10.1016/j.ajic.2024.08.010","DOIUrl":null,"url":null,"abstract":"Background: Chronic obstructive pulmonary disease (COPD) is a risk factor for herpes zoster. Vaccination can prevent or attenuate herpes zoster and its related complications. However, evidence regarding vaccine uptake among patients with COPD is limited. Therefore, this study aimed to evaluate trends in herpes zoster vaccination and characteristics associated with vaccination among US older adults with COPD.Methods: Data from the 2008 to 2022 National Health Interview Survey were used. Participants aged ≥50 years were included. Joinpoint regression analysis was performed to analyze trends in herpes zoster vaccination. A multivariable logistic regression model was used to identify factors associated with vaccination.Results: From 2008 to 2022, an increasing trend in herpes zoster vaccination was observed (average annual percent change = 15.10, P < .01). This increasing trend was also observed when stratified by age groups. Disparities in vaccination were found across several factors, including age, sex, race or ethnicity, region, educational level, health insurance, income, smoking status, perceived health status, and flu and pneumococcal vaccination.Conclusions: There has been an upward trend in herpes zoster vaccination over the past 15 years among older adults with COPD. Disparities across several characteristics existed, underscoring the necessity for targeted policies and interventions to promote equity in vaccination.","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of infection control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajic.2024.08.010","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a risk factor for herpes zoster. Vaccination can prevent or attenuate herpes zoster and its related complications. However, evidence regarding vaccine uptake among patients with COPD is limited. Therefore, this study aimed to evaluate trends in herpes zoster vaccination and characteristics associated with vaccination among US older adults with COPD.

Methods: Data from the 2008 to 2022 National Health Interview Survey were used. Participants aged ≥50 years were included. Joinpoint regression analysis was performed to analyze trends in herpes zoster vaccination. A multivariable logistic regression model was used to identify factors associated with vaccination.

Results: From 2008 to 2022, an increasing trend in herpes zoster vaccination was observed (average annual percent change = 15.10, P < .01). This increasing trend was also observed when stratified by age groups. Disparities in vaccination were found across several factors, including age, sex, race or ethnicity, region, educational level, health insurance, income, smoking status, perceived health status, and flu and pneumococcal vaccination.

Conclusions: There has been an upward trend in herpes zoster vaccination over the past 15 years among older adults with COPD. Disparities across several characteristics existed, underscoring the necessity for targeted policies and interventions to promote equity in vaccination.

查看原文本刊更多论文

2008-2022 年美国患有慢性阻塞性肺病的老年人接种带状疱疹疫苗的全国趋势和差异。

背景：慢性阻塞性肺病（COPD）是带状疱疹的一个危险因素。接种疫苗可以预防或减轻带状疱疹及其相关并发症。然而，有关慢性阻塞性肺病患者接种疫苗的证据却很有限。因此，本横断面研究旨在评估美国患有慢性阻塞性肺病的老年人接种带状疱疹疫苗的趋势以及与接种疫苗相关的特征：方法：采用 2008-2022 年全国健康访谈调查的数据。纳入了年龄≥50 岁的参与者。对带状疱疹疫苗接种趋势进行了连接点回归分析。使用多变量逻辑回归模型确定与带状疱疹疫苗接种相关的因素：这项研究包括 22853 名慢性阻塞性肺病患者，代表了约 980 万患有慢性阻塞性肺病的美国老年人。从 2008 年到 2022 年，带状疱疹疫苗接种率呈上升趋势（年均百分比变化=15.10，PConclusions.COPD）：虽然在过去 15 年中，患有慢性阻塞性肺病的老年人接种带状疱疹疫苗的比例呈上升趋势，但仍发现了几个特征之间的差异。这些发现强调了有必要制定有针对性的政策和干预措施，以促进疫苗接种的公平性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of infection control 医学-传染病学

CiteScore

7.40

自引率

4.10%

发文量

479

审稿时长

24 days

期刊介绍： AJIC covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC)